| OAA0205 | Combining a conditional suicide gene with CCR5 knockout for anti-HIV gene therapy | Oral abstract session with live Q&A | A20 |
| OAA0204 | Tyrosine kinase inhibitors promote antiviral resistance in CD4+ T cells against HIV-1 infection even after treatment withdrawal | Oral abstract session with live Q&A | A21 |
| OAA0203 | Infection outcome in RT-SHIV infected macaques treated early with antiretroviral therapy alone or in combination with the TLR7 agonist vesatolimod | Oral abstract session with live Q&A | A21 |
| OAA0202 | SMAC mimetic plus triple combination bispecific HIVxCD3 DART® molecules in SHIV.CH505-infected, ART-suppressed rhesus macaques | Oral abstract session with live Q&A | A18 |
| OAA0106 | Virological and immunological evaluation of individuals with spontaneous persistent viral control without ART | Oral abstract session with live Q&A | A4 |
| OAA0105 | Assessing the T cell compartment of the extremely rare phenotype of elite control in children | Oral abstract session with live Q&A | A7 |
| OAA0104 | Suppression of HIV-1 linked long non-coding RNAs in viremic HIV-1 positive individuals is associated with ongoing viral replication | Oral abstract session with live Q&A | A15 |
| OAA0103 | In-depth characterization of full-length archived HIV genomes in long-term post-treatment and natural HIV controllers (ANRS CODEX/iVISCONTI Cohort) | Oral abstract session with live Q&A | A4 |
| OAA0102 | Low levels of intact proviral DNA in HIV elite controllers associate with cell-associated HIV RNA and protective HLA alleles | Oral abstract session with live Q&A | A4 |
| LBPEF61 | Biopolitics and governmentality in the age of CoVID-19: Biological citizenship (or lack thereof) of key populations in the response against HIV, HepC & other STIs during a national lockdown | E-poster | F27 |